Neural circuitry and neuroplasticity in mood disorders: insights for novel therapeutic targets
about
Rapid antidepressant effects: moving right alongAntidepressants recruit new neurons to improve stress response regulationThe neurobiological link between OCD and ADHDTargeting the glutamatergic system to treat major depressive disorder: rationale and progress to dateNeurobiology of hedonic tone: the relationship between treatment-resistant depression, attention-deficit hyperactivity disorder, and substance abuseCellular plasticity cascades in the pathophysiology and treatment of bipolar disorderAntipsychotic-like effects of a neurotensin receptor type 1 agonist.Advances in the treatment of anxiety: targeting glutamate.Pharmacological treatments that facilitate extinction of fear: relevance to psychotherapy.Using neuroimaging to evaluate and guide pharmacological and psychotherapeutic treatments for mood disorders in children.Glutamate-modulating drugs as novel pharmacotherapeutic agents in the treatment of obsessive-compulsive disorder.Neuroanatomical pattern of mitochondrial complex I pathology varies between schizophrenia, bipolar disorder and major depression.Review: magnetic resonance spectroscopy studies of pediatric major depressive disorderBDNF val66met polymorphism, white matter abnormalities and remission of geriatric depression.Upward spirals of positive emotions counter downward spirals of negativity: insights from the broaden-and-build theory and affective neuroscience on the treatment of emotion dysfunctions and deficits in psychopathologyIntegrated neurobiology of bipolar disorder.Advances in the treatment of depressionG protein-coupled receptors in major psychiatric disorders.Emerging Novel Treatments for Severe Mood Disorders Involving Cellular Plasticity Cascades.Serotonin versus catecholamine deficiency: behavioral and neural effects of experimental depletion in remitted depression.Basolateral amygdala volume and cell numbers in major depressive disorder: a postmortem stereological studyNK1 receptor antagonists under investigation for the treatment of affective disorders.Pharmacological interventions for bipolar youth: developmental considerations.Repeated administration of imipramine modifies GABAergic transmission in rat frontal cortex.Thiazolidinediones: novel treatments for cognitive deficits in mood disorders?Frontal-subcortical circuitry and behavior.Neurotransmission and bipolar disorder: a systematic family-based association study.Neurobiology of bipolar disorder.Targeting the glutamatergic system to develop novel, improved therapeutics for mood disordersBipolar disorder: from genes to behavior pathwaysRapid onset of antidepressant action: a new paradigm in the research and treatment of major depressive disorder.Neuroplasticity in depressed individuals compared with healthy controlsNeural response to catecholamine depletion in unmedicated subjects with major depressive disorder in remission and healthy subjects.Atrophy of pyramidal neurons and increased stress-induced glutamate levels in CA3 following chronic suppression of adult neurogenesisThe role of hippocampal GluR1 and GluR2 receptors in manic-like behavior.Targeting glutamatergic signaling for the development of novel therapeutics for mood disordersMood disorders and obesity: understanding inflammation as a pathophysiological nexus.Inflammation: a mechanism of depression?A mitochondrial bioenergetic basis of depression.Multimodal approaches to define network oscillations in depression.
P2860
Q24614410-392A91E4-9601-4488-944E-5C4ADE182113Q24634257-801668C6-7EB0-43AB-9066-BCDAB1F4279AQ27002629-97983552-533B-423C-A6AB-00341F787ABCQ27004490-90CCA8AC-4CDE-42A3-8A1B-EC195CDC3C62Q28076105-0D6F8DEC-CFE4-44EE-9984-9244821277BEQ28251880-78044F2F-85A2-49CD-9D41-BFBB7B20C0CCQ30356261-211757B8-67DE-4206-95B4-36B73EE94BD8Q30457479-8AE813BD-38E6-4A23-AAAE-7A47FEEC84E1Q30480038-76C9C7F4-BE3A-432C-85E5-55EB3113F3FFQ30888931-9AF579AE-B327-4FC5-89FE-F26290F5747AQ31032734-53116F59-CA8B-4F33-BAA1-95C02204C028Q33383204-BB27B4E1-309E-47B1-B06D-3012C6AB9047Q33783427-AD3D7209-01C2-4CBF-B013-2B7D94026A84Q33992471-BE3F746C-FD94-4366-B141-D1D647F45097Q34012269-24606480-4AFD-4C96-BB04-4257138391B5Q34080310-D0672A01-9479-4393-91A4-18E3C8B9D15AQ34496251-5625790A-9AC5-4F8C-97D6-3FD1394BB521Q34578414-C554560C-E380-45EE-9A00-570C339D3574Q35006705-3B4368F4-70EC-46F9-A609-CAC630BAA2D9Q35161420-C64065F2-13F5-4F16-86E9-C18A99B9E717Q35305259-FA376183-0BF6-45CA-BE22-F9009702FE34Q36458364-5562FAB1-A27F-42E5-8F2B-2E80D22C56F7Q36634438-A01219FA-C739-43FF-BC2B-FF6151810204Q36781548-EBD000B5-AC02-4CB8-ADE9-5AFE309C7B6CQ36904879-E905AFE3-DCC6-425A-9855-033649FDFAD7Q36922121-F4DF210B-0AD2-4A7B-88E0-B0C71817A9A4Q36952439-95FE77C4-B965-468D-8242-9A3EE9048E70Q37035241-B485EF70-87D2-4242-BAFA-956F9E688A59Q37143117-A8DB2734-90A5-4686-B689-3477D7DD0E48Q37143399-43EFB2CA-AC50-4BBE-9768-29EDA59BBD79Q37147173-02D122B3-6B78-4821-8C83-31F3907CECDEQ37172753-A3257349-53E3-4FBF-B815-7C8BE9CB2FD9Q37178455-A700F45C-D362-4523-B462-D47A95897E79Q37227579-C60E79D7-01FC-45FE-B80D-3E4C71D7F583Q37391006-4C9CD8EF-5265-412A-A8FA-BDF26D0CF3BDQ37481603-EA4B5D2B-C262-4FC8-BD97-27E8C3E611A9Q37821806-ABC5BC32-B984-42BB-BB2B-D5EFC685FF7CQ38212575-CE0563EE-2DE4-4A8F-9E08-1F2DC9557A67Q38254909-2B066D09-D072-4E14-A102-DBE96976C643Q38355592-10B40BC7-FC7E-4F50-803D-E5E587EFD491
P2860
Neural circuitry and neuroplasticity in mood disorders: insights for novel therapeutic targets
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Neural circuitry and neuroplas ...... for novel therapeutic targets
@ast
Neural circuitry and neuroplas ...... for novel therapeutic targets
@en
type
label
Neural circuitry and neuroplas ...... for novel therapeutic targets
@ast
Neural circuitry and neuroplas ...... for novel therapeutic targets
@en
prefLabel
Neural circuitry and neuroplas ...... for novel therapeutic targets
@ast
Neural circuitry and neuroplas ...... for novel therapeutic targets
@en
P2093
P2860
P1433
P1476
Neural circuitry and neuroplas ...... for novel therapeutic targets
@en
P2093
Carlos A Zarate
Husseini K Manji
Jaskaran B Singh
Paul J Carlson
P2860
P356
10.1016/J.NURX.2005.12.009
P577
2006-01-01T00:00:00Z